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Abbreviations: B2M: β2-microglobulin 
                           CLTC: clathrin heavy chain 
                           EGFP: enhanced green fluorescent protein 
                           GTPases: guanosine triphosphatases 
                           pol III: polymerase III 
                           RNAi: RNA interference 
                           SDF-1α: stromal cell-derived factor-1 alpha 
                           shRNA: short hairpin RNA 
                           siRNAs: small interfering RNAs 
 
 
RNA interference (RNAi), mediated by short double-
stranded RNAs, is a powerful mechanism for 
posttranscriptional gene silencing. Sustained expression 
of short hairpin RNA (shRNA) can be accomplished in 
mammalian cells by viral delivery systems. Using 
lentiviral constructs, stable gene silencing is established 
both in dividing and non-dividing cells. Targeting one 
single gene can lead to the development of escape 
mutants or may be insufficient to silence redundant 
pathways. Therefore, simultaneous targeting of multiple 
genes may be necessary. We have generated a lentiviral 
vector-based system for expression of multiple shRNAs 
from a single viral vector, which also encodes an EGFP 
reporter protein. We show that knock-down of each 
single gene from multiple target vectors is achieved at 
an efficiency comparable to that obtained after 
transduction using single target viral vectors. In this 
way, we were able to knock-down several members of 
the human Rho-family GTPases in T cells. Double and 
triple knock-down persisted after multiple passages of 
the cells. The ability to inhibit two or more genes 
simultaneously from one single expression vector 
further widens the application spectrum of RNAi, both 
in functional studies and therapeutic 
strategies.
 
 
Knock-down by small interfering RNAs (siRNAs) has been 
shown to be a powerful technique. Transfer of siRNA to 
cells can be achieved in several ways, e.g. delivered 
exogenously or expressed endogenously from RNA 
polymerase III (pol III) promoters (reviewed by Dykxhoorn 
et al. 2003). Initial reports using siRNA in mammalian cells 
focused on the transient knock-down of target gene 
expression, using direct transfection of synthetic siRNA, or 
transient expression of double stranded RNA via 
transfection of plasmid DNA, bearing a RNA pol III 
promoter-driven expression cassette. 
 
Several reports have also shown the feasibility to knock 
down several proteins simultaneously (Anderson et al. 
2003; Yu et al. 2003; Fitzgerald et al. 2004; Lakka et al. 
2004). Moreover, the combination of siRNAs directed 
against different regions of a single gene can be used to 
improve the gene silencing effect or to avoid viral escape 
mutants (Ji et al. 2003; Gonzalez et al. 2005; Schubert et al. 
2005). Multiple RNAi can be accomplished by transfection 
of multiple siRNA species (Ji et al. 2003; Yu et al. 2003). 
Alternatively, a construct with several consecutive short 
hairpin RNAs (shRNAs) expression cassettes (Gonzalez et 
al. 2005; Jazag et al. 2005; Schubert et al. 2005), or 
expression of a RNA that is cleaved into several shRNAs, 
are an option (Anderson et al. 2003; Lakka et al. 2004). For 
expression in primary cells or cell lines difficult to 
transfect, only viral transfer reaches a significant efficiency 
(Verma and Somia, 1997). More specifically, lentiviral 
vectors have been shown to be a valuable approach for 
stable and effective transfer of functional shRNAs in these 
cells (Qin et al. 2003; Rubinson et al. 2003). To extend the 
application possibilities of lentiviral vector mediated 
knock-down, we developed lentiviral vectors encoding 
within one construct distinct shRNAs, each driven by an 
individual pol III promoter. This ensures simultaneous 
expression of all distinct shRNAs. We show that these 
multiple shRNAs vectors down-modulate the respective 
targets at a comparable level as the single target vectors. As 
proof of principle we used these vectors to silence the 
expression of up to three Rho guanosine triphosphatases 
(GTPases) simultaneously. Rho GTPases are a family of 
regulatory proteins, shown to play a role in different 
functions, such as cellular motility, adhesion and spatial 
organization of membrane receptors and signaling 
molecules (Cantrell, 2003). In hematopoietic cells like T 
cells, several Rho GTPases, e.g. Cdc42, Rac1 and Rac2 are 
expressed. These proteins are highly homologous and can 
have overlapping activity (Cantrell, 2003). Therefore, to 
study their function by knock-down, it might be necessary 
to target several of these small GTPases simultaneously. 
 
In this study, we have examined the functionality of 
different shRNA cassettes, inserted one after the other in a 
single lentiviral construct. We found that these recombinant 
lentiviruses were able to stably knock down the expression 
of the targeted genes on mRNA level as well as on protein 
level. 
 
MATERIALS AND METHODS 
 
Constructs 
 
The pSUPER plasmid containing H1 RNA pol III 
promoter, described previously (Brummelkamp et al. 
2002), was obtained from Oligoengine (Seattle, WA). A 
unique MunI site was inserted downstream the HindIII 
restriction site, creating the pSUPER(MunI) vector. The 
RNAi probes were BglII-HindIII cloned into this vector. To 
construct the 19 nucleotide hairpin siRNA cassettes, two 
complementary DNA oligonucleotides were chemically 
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synthesized (Invitrogen, Merelbeke, Belgium), annealed, 
and inserted immediately downstream of the H1 promoter: 
5'-GATCCCC-19-TTCAAGAGA-19-TTTTTGGAAA-3' 
and 5'-AGCTTTTCCAAAAA-19-TCTCTTGAA-19-GGG-
3'. All siRNA sequences were BLAST searched in the 
National Center for Biotechnology Information's (NCBI, 
http://www.ncbi.nlm.nih.gov/BLAST/) “search for short 
nearly exact matches” mode against all human sequences 
deposited in the GenBank and RefSeq databases and were 
not found to have significant homology (> 17 contiguous 
nucleotides of identity) to genes other than the targets. The 
target sequences for each of the genes were as follows: 
Rac1 (GenBank Accession no. AF498964), 5'-
AGTGGTATCCTGAGGTGCG-3', corresponding to nt 
positions 287-305, Rac2 (GenBank accession no. 
AF498965), 5'-GGACACCATCGAGAAACTG-3', 
corresponding to nt positions 369-387, Cdc42 (GenBank 
accession no. NM_001791), 5'-
GCCTATCACTCCAGAGACT-3', corresponding to nt 
positions 509-527, CLTC (GenBank Accession 
NM_004859), 5'-GTAATCCAATTCGAAGACC-3', 
corresponding to nt positions 413-431 (Motley et al. 2003), 
was used as an irrelevant control. 
 
Lentiviral production was done as described before (Stove 
et al. 2005) using packaging plasmid p8.91 (Zufferey et al. 
1997), vesicular stomatitis virus (VSV) envelope-
expression plasmid (pMD.G) (Naldini et al. 1996) and 
TRIP∆U3-CMV-EGFP-WPRE transfer vector. As MunI 
and EcoRI generate compatible sticky ends, the H1-RNAi 
cassettes could be EcoRI-MunI transferred from the 
pSUPER(MunI) vector into the EcoRI digested TRIP∆U3-
CMV-EGFP-WPRE vector. The EcoRI remains a unique 
restriction site after ligation and can still be used to 
subclone additional H1-RNAi cassettes into the lentiviral 
vector (Figure 1). 
 
Cell culture and viral production 
 
All the cells (SupT1 (AIDS Research and Reference 
Reagent Program, NIH, Bethesda, MD) and 293T 
(American Type Culture Collection, Rockville, MD)) were 
grown in Iscove's modified Dulbecco's medium (IMDM, 
Invitrogen) supplemented with penicillin (100 IU/ml, 
Invitrogen), streptomycin (100 µg/ml, Invitrogen) and 10% 
heat-inactivated fetal calf serum (PerBio,Erembodegem, 
Belgium). VSV-glycoprotein pseudotyped lentiviral  vector  
 
 
 
Figure 1. Representation of RNAi subcloning strategy. Modified pSUPER (MunI) vector carrying the H1-RNAi cassette: a H1-RNA 
promoter driving a shRNA after BglII-HindIII cloning of the encoding dsDNA oligo. From this EcoRI-MunI digested vector, the H1-RNAi 
cassette is cloned into EcoRI digested pTRIP∆U3-CMV-EGFP-WPRE transfer plasmid, leaving one EcoRI site upstream for cloning of 
additional H1-RNAi cassettes. Figure shows relevant part of transfer, packaging and envelope plasmids, which are co-transfected for virus 
production. CMV: Cytomegalovirus minimal promoter; LTR: long terminal repeat; DLTR: partial deleted LTR; RRE: Rev responsive element; 
cPPT: central polypurine tract; WPRE: Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element; VSV-G: Vesicular Stomatitis Virus 
Glycoprotein; polyA: polyadenylation signal; bp: base pairs. 
Stove,  V. et al. 
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particles were produced by co-transfection of 293T cells 
with transfer, packaging and envelope plasmids 
(respectively 20 µg, 20 µg and 10 µg / 175 cm² culture 
flask) using a Calcium Phosphate Transfection Kit 
(Invitrogen) and viral sup was harvested 40 hrs later. Viral 
supernatants contained at least 108 transducing units per ml 
titrated on SupT1 cells. Transductions were carried out in 
the presence of polybrene (4 µg/ml; Sigma-Aldrich, 
Bornem, Belgium) with multiplicity of infection (MOI) 
well above 1. 
 
Chemotaxis 
 
Chemotaxis assays were performed in duplicate using 5 µm 
pore filters (Transwell, 24 well cell cluster, Corning Costar, 
Cambridge, MA) within 10 days after transduction. In order 
to have an internal negative control for migration in each 
well, transduced cells were spiked with non-transduced 
cells to a final ratio of 50% EGFP+/50% EGFP- cells. 
Migration medium (600 µl IMDM supplemented with 
penicillin (100 IU/ml), streptomycin (100 µg/ml) and 0.5% 
bovine serum albumin (Sigma)) containing 10 ng/ml 
recombinant human (SDF-1α/CXCL12; Peprotech, London, 
UK) was added to the lower compartment. Cell suspension 
(5.106 cells/ml in 100 µl) was placed in the upper well. 
Transwells were incubated for 3 hrs at 37ºC, 7% (v/v) CO2. 
 
Upper wells were removed and cells migrated into the 
lower compartment were harvested after addition of a fixed 
amount of Flow-Count Fluorospheres (Beckman Coulter, 
Fullerton, CA). Flow cytometry was done on a 
FACS®Calibur (Becton Dickinson Immunocytometry 
Systems, Mountain View, CA) to determine the absolute 
number of input and migrated cells as well as the relative 
frequency of EGFP+ cells in initial and migrated 
population. Percentage of migrating cells was calculated as 
follows: (%EGFP+ cells in migrated population x total 
amount of migrated cells) / (%EGFP+ cells in initial 
population x total amount of input cells).  
Real-time PCR 
 
Total RNA was extracted from sorted shRNA transduced 
cells as instructed by supplier (TRIzol, Invitrogen), DNase-
treated (DNase I, Invitrogen) and reverse transcribed 
(Reverse Transcription Core Kit, Eurogentec, Seraing, 
Belgium). Genes assayed included Rac1, Rac2 and Cdc42 
(TaqMan detection chemistry, Eurogentec) and β2-
microglobulin housekeeping gene (B2M) (Sybr Green I 
detection, Eurogentec). Primers (Invitrogen) and Taqman 
probes (Eurogentec) were described previously (Kovacic et 
al. 2001; Vandesompele et al. 2002) or were designed with 
Primer Express 2.0 software (Applied Biosystems, Foster 
City, CA). Sequences were as follows (5' to 3'): Rac1 
(Kovacic et al. 2001) forward 
CCCTATCCTATCCGCAAACA; reverse 
CGCACCTCAGGATACCACTT; probe FAM-
TCCCTTGTGAGTCCTGCATCA-TAMRA; Rac2 forward 
TCCGGCCGCTCTCCTATC; reverse 
CGCACTTCTGGGAACCACTT; probe FAM-
TCCTCATCTGCTTCTCCTCGTCAGC-TAMRA; Cdc42 
forward CGTGACCTGAAGGCTGTCAA; reverse 
ACACACCTGCGGCTCTTCTT; probe FAM-
TTGCTTCGTCAAATACATTCTTTAGGCCTTTCTG-
TAMRA; B2M (Vandesompele et al. 2002) forward 
TGCTGTCTCCATGTTTGATGTATCT; reverse 
TCTCTGCTCCCCACCTCTAAGT. Dyes used were 6-
carboxyfluorescein (FAM) and 6-carboxy-
tetramethylrhodamine (TAMRA). Quantitative real-time 
PCR was performed on ABI Prism 7000 Sequence 
Detection System (Applied Biosystems). Cycle conditions 
were 10 min at 95ºC, 40 cycles of 95ºC for 15 sec and 60ºC 
for 1 min. For each PCR run with Sybr Green I, a melting 
curve analysis was performed to guarantee the 
amplification specificity. All amplifications were done in 
triplicate runs and included a standard curve of serial 
dilutions of total thymus cDNA, no-template control and 
samples of approximately 25 ngeq RNA, all in triplicate. 
For genes assayed with TaqMan detection chemistry, 
reaction mixture contains 900 nM primer and 200 nM 
probe. For genes assayed with Sybr Green I, final primer 
concentration is 300 nM.  
 
Western blotting 
 
Sorted transduced cells were lysed in Laemmli sample 
buffer (0.125 M Tris [pH 6.8], 25% Glycerol, 2.3% SDS), 
and the protein concentrations were determined by RC DC 
Protein Assay (Bio-Rad, Nazareth, Belgium). After adding 
5% 2-mercapto-ethanol and boiling, equal amounts of 
protein were run on a 12% precast Novex Tris-Glycine 
polyacrylamide gel (Invitrogen) in reducing conditions and 
blotted onto nitrocellulose membranes (Amersham 
Biosciences, Roosendaal, The Netherlands). Quenching and 
immunostaining of the blots was done in 5% non-fat dry 
milk in phosphate-buffered saline containing 0.5% Tween-
20. The membranes were quenched for 1 hr, incubated with 
primary antibody (Ab) for 1 hr, washed four times for 10 
min, incubated with horseradish peroxidase-conjugated 
secondary Ab (Amersham Biosciences) for 45 min and 
washed six times for 10 min. Primary Abs used included 
 
Figure 2. EGFP expression in transduced SupT1 cells. Flow 
cytometric EGFP expression profile of SupT1 cells, transduced 
with virus encoding single Rac2 shRNA (filled histograms), 
tandem Rac2 and Rac1 shRNA (black line) and triple Cdc42, 
Rac2 and Rac1 shRNA (grey line) before (a) and after (b) sorting 
for EGFP expression. Markers E- to E+++ indicate expression 
intervals used in chemotaxis experiments (see text and Figure 
5).   
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anti-Rac Ab (mouse, monoclonal, Upstate Biotechnology, 
Waltham, MA), anti-Rac2 Ab (rabbit polyclonal, C-11, 
Santa Cruz Biotechnology, Santa Cruz, CA) and anti-
Cdc42 Ab (P1, Santa Cruz). Detection was done using 
enhanced chemiluminescence reagent (Amersham 
Biosciences) or Supersignal West Femto (Pierce, Rockford, 
IL) as a substrate. For normalization of lysate loading, 
immunostaining with a mouse anti-Actin antibody (mouse 
monoclonal, cloneC4, ICN, Aurora, OH) was performed 
(not shown). Quantification was done using an Image 
Station 440CF chemoluminescence imager (Kodak, Hemel 
Hempstead, UK) and Quantity One software (Bio-Rad). 
 
RESULTS  
 
Lentiviral delivery of shRNAs targeted to a single 
Rho GTPase gene 
 
Several shRNAs - 2 shRNAs per targeted gene - were 
synthesized corresponding to the genes Rac1, Rac2 and 
Cdc42. Each shRNA also served as negative control for the 
two other, non-targeted genes. Furthermore, a shRNA 
targeting clathrin heavy chain (CLTC) was chosen as an 
additional control. To investigate the potency of the 
selected short hairpins to stably knock down their 
respective target, we designed lentiviral constructs 
expressing a shRNA from the pol III promoter H1 and an 
enhanced green fluorescent protein (EGFP) reporter from a 
CMV internal promoter. Both directions were possible for 
insertion of the siRNA cassette with equal capacity to 
knock down the target gene (data not shown). For 
simplicity, all the constructs were built with the internal 
promoters 5'-3' (Figure 1). Due to its consistent high Rac1, 
Rac2 and Cdc42 expression levels, the SupT1 T-cell line 
was chosen to verify the effectiveness of the shRNAs. 
Following transduction, cells were sorted for comparable 
EGFP levels, as shown for Rac2 RNAi in Figure 2. In a 
next step, Rac1, Rac2 and Cdc42 expression levels were 
assayed by Western blotting (Figure 3) and real-time PCR 
(Figure 4). For each gene the shRNA with the strongest 
knock-down was selected. As shown in Figure 3, in cells 
transduced with single shRNA expressing virus, targeted 
protein expression was 6 to 17-fold less than in control 
transduced cells, while the other Rho GTPase proteins 
tested for were not affected, or showed an even higher 
expression level. A similar ablation was seen in mRNA 
expression (Figure 4). In conclusion, these assays showed a 
clear reduction of targeted gene expression, at mRNA and 
protein level, without diminishing that of the other Rho 
GTPases assayed for. This illustrates that in our 
experimental set-up the selected shRNAs were expressed at 
sufficient level to trigger stable, strong and gene-specific 
silencing.  
 
Simultaneous knock-down of 2 or 3 Rho GTPase 
genes 
 
To test the effectiveness of simultaneous knock-down of 
multiple genes, we inserted 2, and in a next step 3 RNAi 
cassettes 5'-3' into the TRIP vector (further referred to as 
tandem and triple RNAi). To this end, the H1-RNAi 
cassettes were consecutively EcoRI-MunI transferred from 
the pSUPER(MunI) vector into the EcoRI digested 
TRIP∆U3-CMV-EGFP-WPRE vector. The restriction site 
EcoRI remains unique after ligation and can still be used to 
subclone additional H1-RNAi cassettes into the lentiviral 
transfer vector (Figure 1). Again, functionality of tandem 
and triple RNAi constructs was assayed by Western 
blotting and real-time PCR (Figure 3 and Figure 4) after 
sorting of transduced cells for comparable EGFP levels 
(Figure 2b). On the protein level, reduction in target gene 
expression was as strong as seen with single shRNA 
expressing viruses (Figure 3), although mRNA levels were 
less reduced (Figure 4). Similar experiments using the 
Jurkat T-cell line yielded the same results (data not shown). 
Overall, these experiments showed that multiple shRNAs, 
expressed from the same lentiviral vector, are present at 
sufficient level to knock down multiple targets. Knock-
down persisted over at least 20 cell divisions, and lasted for 
some targets for over 1 month of continuous cell culture 
(data not shown). 
 
Functional implications of knock-down of Rho 
GTPases 
 
Rho GTPases are crucial proteins for directed cell 
migration (Raftopoulou and Hall, 2004). To investigate the 
functional correlate of the observed knock-down, we 
performed migration assays with SupT1 cells, known to 
respond chemotactically to stromal cell-derived factor-1 
alpha (SDF-1α (Secchiero et al. 1998). In these 
experiments, RNAi transduced cells were not sorted, 
allowing us to score migration in function of EGFP 
expression (gating on intensity regions as shown in Figure 
2a, E- to E+++). As shown in Figure 5, knock-down of Rac1, 
Rac2 and Cdc42 all resulted in impaired chemotaxis 
towards SDF-1α. Inhibition of migration correlated with 
EGFP levels, indicating a biological read-out of the shRNA 
levels. Cells expressing shRNA migrated to a lower extent 
compared to cells not expressing shRNA when either one 
of the three Rho GTPases was knocked down, suggesting 
Figure 3. Immunoblot of lysates from sorted SupT1 cells, 
expressing specific RNAi as indicated. Each row represents blot 
stained with antibody as indicated in the left margin. Figures below 
band are protein quantities, normalized for actin content (not shown) 
and relative to CLTC RNAi control. The results shown are 
representative of three independent experiments. 
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that targeted Rho GTPase proteins are all necessary for 
directional migration. Consequently, as expected from 
knock-down observed by immunoblot, this biological effect 
was retained in cells transduced with virus encoding 
multiple shRNAs (Figure 5). 
 
DISCUSSION 
 
In this report, we generated lentiviral constructs to study 
knock-down of Rho GTPases, important in cell motility. 
Simultaneous knock-down of several individual Rho 
GTPases was achieved with multiple siRNAs, each driven 
by individual H1 pol III promoters, expressed from a single 
lentiviral vector. Thanks to a separate marker gene insert, 
the dose-response on knock-down can be monitored. 
 
In order to establish stable silencing of Rho GTPases, 
lentiviral constructs expressing shRNA were designed. 
Lentiviral gene transfer has been shown to be an efficient 
and gentle method to transfer siRNA into primary cells and 
by virtue of a marker gene, transduced cells effectively 
expressing shRNA can be identified. For effective knock-
down of signaling cascades or redundant protein pathways, 
several targets have to be silenced in the same cell. In this 
study, we further extended the use of lentiviral siRNA 
transgenesis by generating tandem and triple constructs to 
achieve multiple protein knock-down. These constructs 
have an advantage over simultaneous transfection of 
several siRNAs, as the latter method does not ensure that 
all siRNAs are expressed simultaneously. Alternatively, 
multiple transductions with separate viruses, each encoding 
one shRNA, are feasible if high transduction efficiencies 
are attained. However, unless each vector encodes a 
different marker gene, it remains unclear if a single cell 
expresses all shRNAs intended to be transferred. Moreover, 
expression from a single vector has the advantage that the 
relative level of expression of each shRNA is constant. A 
method using plasmids expressing multiple siRNAs driven 
by U6 promoters to achieve knock down of escape mutants 
of a single target (Schubert et al. 2005) or to target different 
mRNAs (Jazag et al. 2005) were described recently. These 
and our results indicate that no apparent competition exists 
between multiple pol III promoters in close proximity and 
that no saturation of the RNA-induced silencing complex 
RISC was reached, as suggested previously (McManus et 
al. 2002). Moreover, Gonzalez et al. 2005 have recently 
reported a proportional improvement in HLA gene 
silencing by increasing the copy number of a selected U6-
shRNA cassette in the plasmid vector from 1 to 6. Further 
increasing the number of RNAi cassettes showed a decrease 
in HLA down-regulation, evidencing a certain limit 
(competition or saturation) in shRNA expression capacity. 
However, this limit might be different depending on the 
targeted gene and the cell line or vector system that is used. 
Recently, reports have shown that simultaneous silencing of 
two different cellular targets is achievable using a single 
lentiviral vector containing two pol III promoters 
(Anderson and Akkina, 2005; Sumimoto et al. 2006). Our 
data corroborate these results and provide evidence that 
knock-down of three different targets from one type of pol 
III promoter is still feasible. Moreover, our design allows 
an easy gradual extension of the number of RNAi cassettes 
in the widely used lentiviral vector pTRIP, which can, 
based on its theoretical incorporation capacity (Verma and 
Somia, 1997), accommodate more than 10 shRNA 
cassettes. In this context of multiple identical promoter 
sequences in a row, the possibility of repeat sequence-
mediated deletion during reverse transcription should be 
considered. However, we hypothesize that the net effect of 
this phenomenon might be minimal when using high MOI. 
The evaluation of other and more sets of shRNAs is 
warranted and currently in progress. 
 
Recently, nonspecific effects of siRNAs on gene expression 
have been reported (reviewed by Dykxhoorn and 
Lieberman, 2005). In our experiments, we did not observe 
‘off-target' stimulation or repression for the investigated 
genes. Some protein quantification results showed higher 
protein levels of non-targeted Rho GTPases. However, this 
effect was not observed on mRNA level. Moreover, Rac1 
could not compensate for loss of function of Rac2 and vice 
versa in the chemotaxis assay. Interestingly, inhibition of 
migration correlated with EGFP levels, demonstrating that 
the marker gene expression, although driven by a separate 
promoter, is a reliable measure for shRNA levels. This 
validates our approach of sorting similar EGFP intensities 
in transduced cells for direct comparison of the effect of 
shRNA expression. Moreover, the potential caveat of 
comparing different vector stocks with different MOI is 
avoided by this approach. Further functional experiments 
are needed to delineate the Rho GTPase network response 
to knock-down of individual members using our vectors.  
 
In conclusion, we present here a lentiviral shRNA delivery 
system that allows multiple shRNA species and a marker 
gene to be expressed from the same vector. The 
simultaneous knock-down of several targets within the 
same cell may be necessary, e.g. in compensatory or 
redundant pathways that have to be blocked at several 
levels, or to target hyper-variable viral sequences. 
Therefore, this strategy will likely prove to be of value in 
experimental and therapeutic applications. 
 
 
Figure 4. Messenger RNA expression of sorted SupT1 cells, 
expressing specific RNAi as indicated. Bars indicate mean 
expression levels for Rac1 (black), Rac2 (grey) and Cdc42 
(open); error bars indicate SD on at least three experiments. For 
comparison, levels are normalized to that of CLTC RNAi control. 
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